StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Currency / FX Impact (% pts) by Quarter

Currency / FX Impact (% pts) (%)

QuarterlyAnnual

Novartis Currency / FX Impact (% pts): 0.0% in Q3 2026, down 1.0 pts from a year earlier.

Latest, Q3 2026
0.0%
Period ended Sep 30, 2026
Change on a year earlier
-1.0 pts
1.0% in Q3 2025
History
27 quarters
Since Q1 2020
Sources
27
Documents cited below

Where the Q3 2026 figure comes from

“|| Net sales to third parties | 4 | 4 | 0”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K (Operating Review).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCurrency / FX Impact (% pts) (%)Year on yearSource
Q3 2026Sep 30, 20260.0%-1.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20262.0%+1.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20264.0%+7.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20252.0%+3.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20251.0%+2.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20251.0%+3.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 2025-3.0%-2.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 2024-1.0%+1.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 2024-1.0%-1.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 2024-2.0%+2.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 2024-1.0%+3.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 2023-2.0%+6.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 20230.0%+11.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023-4.0%+4.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023-4.0%+2.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-8.0%-6.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Currency / FX Impact (% pts) (%), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/bridge-currency-pp

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.